Kepos Capital’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Kepos Capital’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-80,000	Closed	-$17K	–	325
2023 Q2	$17K	Buy	+80,000	New	+$14.1K	﹤0.01%	291
2022 Q4	$7K	Hold	80,000	–	–	﹤0.01%	380
2022 Q3	$12K	Sell	80,000 -25,000	-24%	-$4.3K	﹤0.01%	403
2022 Q2	$27K	Hold	105,000	–	–	﹤0.01%	398
2022 Q1	$64K	Hold	105,000	–	–	﹤0.01%	473
2021 Q4	$121K	Buy	+105,000	New	+$107K	0.01%	478

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Kepos Capital's NKGNW Position: Q3 2023 in Review

Kepos Capital sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q3 2023, closing a stake of 80,000 shares — an estimated $17K sold.

Kepos Capital first reported a position in NKGNW in Q4 2021 and held it in 6 quarters. The position peaked at $121K in Q4 2021. 21 funds tracked by Wall St. Rank hold NKGNW as of Q3 2023.

Kepos Capital reported no remaining NKGen Biotech, Inc. Warrants position as of Q3 2023 after selling out during the quarter.
Kepos Capital sold 80,000 NKGen Biotech, Inc. Warrants shares in Q3 2023, an estimated $17K.
Kepos Capital first reported a position in NKGen Biotech, Inc. Warrants in Q4 2021 and held it in 6 quarters.
Kepos Capital's NKGen Biotech, Inc. Warrants position peaked at $121K in Q4 2021.
21 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q3 2023.

Based on Kepos Capital's 13F filing for Q3 2023, filed 14 Nov 2023.